• ABOUT ELITE
    • Overview
    • Our Facility
    • Management & Key Employees
    • Our Board
    • Careers
  • PRODUCTS
  • PIPELINE
    • Generic
    • Branded
  • TECHNOLOGY
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
logo image
HOME | CAREERS | CONTACT | NEWS |
Share
Skip to content
  • About Elite
    • Overview
    • Management & Key Employees
    • Our Board
    • Careers
  • Products
  • Pipeline
    • Generic
    • Branded
  • Technology
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • Investor Relations
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
    • Investor Relations
    • Press Releases
    • Events &
      Presentations
    • SEC Filings
    • Shareholder
      Meeting
    • Governance
      Documents
    • Investor Contacts
    • Email Alerts

Press Releases

 
Select:
Apr 21, 2015
Elite Pharmaceuticals Announces Launch of Generic Hydroxyzine Tablets

Feb 17, 2015
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2015

Feb 17, 2015
Elite Pharmaceuticals Provides Guidance on Phase III Study for ELI-200

Feb 12, 2015
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, February 18, 2015

Jan 15, 2015
Elite Pharmaceuticals Announces First Shipment of Generic Isradipine Capsules

Dec 16, 2014
Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation

Nov 14, 2014
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015

Sep 09, 2014
Elite Pharmaceuticals Releases Positive Top Line Human Abuse Liability Data For Eli-200, An Opioid Abuse Deterrent Product

Sep 03, 2014
Elite Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th

Aug 14, 2014
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2015

 7   8   9   10   11     12    13   14   15   16   17 
 <<   <   >   >> 
  • Site Map   |  Privacy  |  Terms Of Use
Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.
ART™: Abuse-Resistant Technology for a safer healthier you.
Back to top

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window